Combiprasal - Ipratropium with salbutamol
TriOn Pharma
Description
Ipratropium with short-acting selective beta2 agonist.
For the treatment of bronchospasm in COPD
Adult: 0.5/2.5 mg 3–4 times a day.
Indications
For the treatment of bronchospasm in COPD.
Preparations Available
Nebuliser liquid
Sizes Available
Nebuliser liquid
Combiprasal 0.5/2.5 mg, 2.5 ml, 60 units
More on: Bronchodilators , Short-acting selective beta2: agonists